WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 522700
CAS#: 1000998-59-3
Description: BMS-687453 is a potent and selective peroxisome proliferator activated receptor (PPAR) alpha agonist. with an EC(50) of 10 nM for human PPARalpha and approximately 410-fold selectivity vs human PPARgamma in PPAR-GAL4 transactivation assays. BMS-687453 demonstrated an excellent pharmacological and safety profile in preclinical studies and thus was chosen as a development candidate for the treatment of atherosclerosis and dyslipidemia.
MedKoo Cat#: 522700
Name: BMS-687453
CAS#: 1000998-59-3
Chemical Formula: C22H21ClN2O6
Exact Mass: 444.1088
Molecular Weight: 444.868
Elemental Analysis: C, 59.40; H, 4.76; Cl, 7.97; N, 6.30; O, 21.58
Synonym: BMS-687453; BMS 687453; BMS687453.
IUPAC/Chemical Name: N-(3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)-N-(methoxycarbonyl)glycine
InChi Key: UJIBXDMNCMEJAY-UHFFFAOYSA-N
InChi Code: InChI=1S/C22H21ClN2O6/c1-14-19(24-21(31-14)16-6-8-17(23)9-7-16)13-30-18-5-3-4-15(10-18)11-25(12-20(26)27)22(28)29-2/h3-10H,11-13H2,1-2H3,(H,26,27)
SMILES Code: O=C(O)CN(CC1=CC=CC(OCC2=C(C)OC(C3=CC=C(Cl)C=C3)=N2)=C1)C(OC)=O
1: Li J, Kennedy LJ, Shi Y, Tao S, Ye XY, Chen SY, Wang Y, Hernández AS, Wang W,
Devasthale PV, Chen S, Lai Z, Zhang H, Wu S, Smirk RA, Bolton SA, Ryono DE, Zhang
H, Lim NK, Chen BC, Locke KT, O'Malley KM, Zhang L, Srivastava RA, Miao B, Meyers
DS, Monshizadegan H, Search D, Grimm D, Zhang R, Harrity T, Kunselman LK, Cap M,
Kadiyala P, Hosagrahara V, Zhang L, Xu C, Li YX, Muckelbauer JK, Chang C, An Y,
Krystek SR, Blanar MA, Zahler R, Mukherjee R, Cheng PT, Tino JA. Discovery of an
oxybenzylglycine based peroxisome proliferator activated receptor alpha selective
agonist
2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)am
ino)acetic acid (BMS-687453). J Med Chem. 2010 Apr 8;53(7):2854-64. doi:
10.1021/jm9016812. PubMed PMID: 20218621.
2: Vassallo JD, Janovitz EB, Wescott DM, Chadwick C, Lowe-Krentz LJ,
Lehman-McKeeman LD. Biomarkers of drug-induced skeletal muscle injury in the rat:
troponin I and myoglobin. Toxicol Sci. 2009 Oct;111(2):402-12. doi:
10.1093/toxsci/kfp166. Epub 2009 Jul 23. PubMed PMID: 19628585.
3: Mukherjee R, Locke KT, Miao B, Meyers D, Monshizadegan H, Zhang R, Search D,
Grimm D, Flynn M, O'Malley KM, Zhang L, Li J, Shi Y, Kennedy LJ, Blanar M, Cheng
PT, Tino J, Srivastava RA. Novel peroxisome proliferator-activated receptor alpha
agonists lower low-density lipoprotein and triglycerides, raise high-density
lipoprotein, and synergistically increase cholesterol excretion with a liver X
receptor agonist. J Pharmacol Exp Ther. 2008 Dec;327(3):716-26. doi:
10.1124/jpet.108.143271. Epub 2008 Sep 17. PubMed PMID: 18799592.
